PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-05
DOI
10.1038/s41598-018-22594-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
- (2017) Christian Uprimny et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prediction of the Pathologic Gleason Score to Inform a Personalized Management Program for Prostate Cancer
- (2017) R. Yates Coley et al. EUROPEAN UROLOGY
- Immunohistochemical Validation of PSMA Expression Measured by68Ga-PSMA PET/CT in Primary Prostate Cancer
- (2017) Nadine Woythal et al. JOURNAL OF NUCLEAR MEDICINE
- Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
- (2016) Matthias Eiber et al. EUROPEAN UROLOGY
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
- (2016) Lars Budäus et al. EUROPEAN UROLOGY
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Marlon Perera et al. EUROPEAN UROLOGY
- Clarifying the PSA grey zone: The management of patients with a borderline PSA
- (2016) Talisa Ross et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer
- (2016) W. P. Fendler et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
- (2015) Ugo De Giorgi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients
- (2015) Vincenza Conteduca et al. Future Oncology
- 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
- (2015) M. Weineisen et al. JOURNAL OF NUCLEAR MEDICINE
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies
- (2014) Vincenza Conteduca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search